Intra-host competition between nef–defective escape mutants and wild–type human immunodeficiency virus type 1
暂无分享,去创建一个
[1] David C. Krakauer,et al. Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies , 1998, Journal of Virology.
[2] D. Krakauer,et al. T–cell induced pathogenesis in HIV: bystander effects and latent infection , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[3] K. Sigmund,et al. On the stabilizing effect of predators and competitors on ecological communities , 1989, Journal of mathematical biology.
[4] R. Desrosiers,et al. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. , 1994, AIDS research and human retroviruses.
[5] B. Walker,et al. Systematic Identiflcation of Optimal HIV-1 CTL Epitopes , 1997 .
[6] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[7] T. Greenough,et al. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. , 1997, Virology.
[8] L. Loeb,et al. Fidelity of HIV-1 reverse transcriptase. , 1988, Science.
[9] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[10] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Richman,et al. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes , 1994, The Journal of experimental medicine.
[12] Predominance of defective proviral sequences in an HIV + long-term non-progressor. , 1996, Immunology letters.
[13] R. Redfield,et al. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.
[14] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[15] R. Bronson,et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. , 1995, Science.
[16] T. Greenough,et al. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection , 1996, Journal of virology.
[17] M. Woolhouse,et al. Immune avoidance strategies in RNA viruses: fitness continuums arising from trade-offs between immunogenicity and antigenic variability. , 1998, Journal of theoretical biology.
[18] S. Rowland-Jones,et al. Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 , 1999, Journal of Virology.
[19] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[20] R. Desrosiers,et al. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.
[21] H. Clifford Lane,et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression , 1995, Nature Medicine.
[22] G. Shaw,et al. Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.
[23] M A Nowak,et al. Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.
[24] A. McMichael,et al. Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells , 1997, The Journal of experimental medicine.
[25] J. Mills,et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. , 1999, The New England journal of medicine.
[26] J. Levy,et al. Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein , 1995, Journal of virology.
[27] J. S. Sullivan,et al. Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.
[28] Is the Nef protein of HIV-1 required for pathogenesis? , 1996, Trends in microbiology.
[29] O. Diekmann,et al. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.
[30] M A Nowak,et al. Defective escape mutants of HIV. , 1994, Journal of theoretical biology.
[31] R. Desrosiers,et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.
[32] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[33] M. Nowak,et al. Can live attenuated virus work as post-exposure treatment? , 1995, Immunology today.
[34] H. Moriyama,et al. Infectivity and Immunogenicity of SIVmac/HIV‐1 Chimeric Viruses (SHIVs) with Deletions in Two or Three Genes (vpr, nef and vpx) , 1998, Microbiology and immunology.
[35] M. Nowak,et al. A mathematical model of vaccination against HIV to prevent the development of AIDS , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[36] H. McClure,et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques , 1999, Nature Medicine.
[37] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Fuchs,et al. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion. , 1996, Immunology letters.
[39] R. Swanstrom,et al. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.
[40] B. Berkhout,et al. Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains , 1999, Journal of Virology.
[41] A. di Caro,et al. Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor , 1998, Journal of Virology.
[42] Y. Kuznetsov,et al. Continuation techniques and interactive software for bifurcation analysis of ODEs and iterated maps: physics , 1993 .
[43] T. Leitner,et al. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Cheng‐Mayer,et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.
[45] S. Frost,et al. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.
[46] A. Whatmore,et al. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence , 1995, Journal of virology.
[47] R. Phillips,et al. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. , 1997, AIDS.
[48] M A Nowak,et al. The effect of different immune responses on the evolution of virulent CXCR4–tropic HIV , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[49] David Looney,et al. Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.
[50] D. Montefiori,et al. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus , 1996, Journal of virology.
[51] C. Benson,et al. Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .
[52] W. Greene,et al. Unraveling the function of HIV type 1 Nef. , 1996, AIDS research and human retroviruses.
[53] M. Harris. From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. , 1996, The Journal of general virology.
[54] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[55] R. Phillips,et al. Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef. , 1997, AIDS.
[56] D. Trono,et al. The Nef protein of primate lentiviruses , 1999, Reviews in Medical Virology.
[57] J. Skowroński,et al. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[58] T. Greenough,et al. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. , 1999, The New England journal of medicine.
[59] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[60] E. Holmes,et al. Genetic Drift of Human Immunodeficiency Virus Type 1? , 1998, Journal of Virology.